The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Feb. 05, 2015
Applicant:

Stemnion, Inc., Pittsburgh, PA (US);

Inventors:

Richard A. Banas, Turtle Creek, PA (US);

Catherine J. Trumpower, Pittsburgh, PA (US);

Vivienne S. Marshall, San Antonio, TX (US);

Assignee:

STEMNION, INC., Pittsburgh, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/12 (2006.01); C12N 5/078 (2010.01); A61K 35/50 (2015.01); A61K 35/12 (2015.01); A61K 38/17 (2006.01); A61K 38/21 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61K 35/12 (2013.01); A61K 38/1709 (2013.01); A61K 38/21 (2013.01); A61K 39/001 (2013.01); A61K 39/3955 (2013.01); C12N 5/0634 (2013.01); A61K 2039/5158 (2013.01); C12N 2502/025 (2013.01);
Abstract

The invention is directed to novel methods for modulating inflammatory and/or immune responses. Such methods utilize compositions comprising extraembryonic cells (herein referred to as EE cells) including but not limited to extraembryonic HLA-G positive cells (herein referred to as EHP cells) and amnion-derived multipotent progenitor cells (herein referred to as AMP cells); compositions comprising expanded EE cell populations, and/or cell lysates and/or conditioned media derived therefrom, alone or in combination with each other and/or in combination with various extracellular matrices and/or devices and/or other suitable active agents.


Find Patent Forward Citations

Loading…